Human cancer virus vaccines and the pursuit of the practical
β Scribed by Dr. Maurice R. Hilleman
- Publisher
- John Wiley and Sons
- Year
- 1974
- Tongue
- English
- Weight
- 665 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
TABLE 1 Results From an Ad Hoc Meeting Conducted by the Pan American Health Organization on Important Biologic Endpoints for Human Papillomavirus Vaccine Surveillance Endpoints for HPV Surveillance and Measurement Indicators Endpoint Measurement Indicator Genital HPV infections Changes in prevalence
A procedure to attenuate live influenza virus of type A and type B was developed using adaptation of the virus to grow at 25 degrees C (cold adaptation; ca). Through a series of stepwise passages, two stable mutants were obtained and designated as 'Master' strains, one for type A influenza virus (A/
## Abstract ## BACKGROUND. The objective of this study was to compare the human immunodeficiency virus (HIV) viral load (VL) and CD4 counts in patients infected with HIV with and without cervical cancer. The authors hypothesized that HIVβpositive women with cervical cancer would have a greater ris
## Abstract The relative ability of a varicellaβzoster virus (VZV) clinical isolate and a live attenuated VZV vaccine strain (Oka) to infect human neurons was determined in vitro. VZV infection of neurons prepared in culture from dorsal root ganglia of fetuses was assessed using an infectious cente